10.97
price up icon3.98%   0.42
after-market After Hours: 10.97
loading
Fibrogen Inc stock is traded at $10.97, with a volume of 16,206. It is up +3.98% in the last 24 hours and down -8.81% over the past month. FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
See More
Previous Close:
$10.55
Open:
$10.78
24h Volume:
16,206
Relative Volume:
0.38
Market Cap:
$44.36M
Revenue:
$147.75M
Net Income/Loss:
$-284.23M
P/E Ratio:
-3.744
EPS:
-2.93
Net Cash Flow:
$-317.54M
1W Performance:
-3.01%
1M Performance:
-8.81%
6M Performance:
+58.30%
1Y Performance:
+22.81%
1-Day Range:
Value
$10.46
$11.09
1-Week Range:
Value
$10.29
$11.55
52-Week Range:
Value
$4.50
$21.94

Fibrogen Inc Stock (FGEN) Company Profile

Name
Name
Fibrogen Inc
Name
Phone
415-978-1200
Name
Address
350 BAY STREET, SAN FRANCISCO, CA
Name
Employee
225
Name
Twitter
@FibroGenInc
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
FGEN's Discussions on Twitter

Compare FGEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
FGEN
Fibrogen Inc
10.97 42.66M 147.75M -284.23M -317.54M -2.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-08-23 Downgrade BofA Securities Neutral → Underperform
Jun-26-23 Downgrade BofA Securities Buy → Neutral
Jun-26-23 Downgrade Raymond James Outperform → Mkt Perform
Jun-26-23 Downgrade Stifel Buy → Hold
Jun-26-23 Downgrade William Blair Outperform → Mkt Perform
Jun-02-23 Upgrade Stifel Hold → Buy
Jan-31-23 Upgrade William Blair Mkt Perform → Outperform
Jan-26-23 Upgrade Raymond James Mkt Perform → Outperform
Jan-05-23 Upgrade BofA Securities Neutral → Buy
Sep-22-21 Downgrade Goldman Neutral → Sell
Aug-20-21 Upgrade Raymond James Underperform → Mkt Perform
Jul-16-21 Downgrade BofA Securities Buy → Neutral
Jul-16-21 Downgrade Stifel Buy → Hold
Apr-07-21 Downgrade H.C. Wainwright Buy → Neutral
Apr-07-21 Downgrade Mizuho Buy → Neutral
Mar-31-21 Upgrade BofA Securities Neutral → Buy
Mar-02-21 Downgrade Jefferies Buy → Hold
Feb-01-21 Initiated H.C. Wainwright Buy
Oct-26-20 Initiated Raymond James Underperform
Jul-10-20 Resumed Stifel Buy
May-01-20 Initiated Cowen Market Perform
Apr-27-20 Initiated BofA/Merrill Neutral
May-29-19 Resumed Goldman Neutral
May-10-19 Downgrade William Blair Outperform → Mkt Perform
Apr-12-19 Initiated Piper Jaffray Neutral
Feb-11-19 Resumed Stifel Buy
Dec-19-18 Upgrade Citigroup Neutral → Buy
Aug-08-17 Reiterated Leerink Partners Outperform
Aug-08-17 Reiterated Stifel Buy
Jul-21-17 Downgrade Goldman Buy → Neutral
Jul-11-17 Initiated Jefferies Buy
Feb-11-16 Upgrade Credit Suisse Neutral → Outperform
Jan-21-16 Initiated Credit Suisse Neutral
Dec-04-15 Initiated Citigroup Buy
Sep-23-15 Initiated Lake Street Hold
Jul-29-15 Initiated Citigroup Buy
Jul-20-15 Upgrade Goldman Neutral → Buy
Dec-09-14 Initiated Stifel Buy
View All

Fibrogen Inc Stock (FGEN) Latest News

pulisher
11:35 AM

How FibroGen Inc. (1FG0) stock reacts to monetary easingWatch List & Technical Buy Zone Confirmation - newser.com

11:35 AM
pulisher
10:26 AM

Forecasting FibroGen Inc. price range with options dataJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com

10:26 AM
pulisher
02:08 AM

How to read the order book for FibroGen Inc.Earnings Overview Report & Advanced Swing Trade Entry Plans - newser.com

02:08 AM
pulisher
Oct 10, 2025

Real time breakdown of FibroGen Inc. stock performance2025 Short Interest & Growth Oriented Trading Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Risk vs reward if holding onto FibroGen Inc.Market Rally & AI Driven Price Predictions - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Sentiment analysis tools applied to FibroGen Inc.July 2025 Technicals & High Conviction Buy Zone Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Applying Wyckoff theory to FibroGen Inc. stockInflation Watch & Consistent Return Investment Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Can you recover from losses in FibroGen Inc.Market Growth Summary & Real-Time Volume Analysis - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Relative strength of FibroGen Inc. in sector analysis2025 Historical Comparison & Verified Short-Term Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Custom watchlist performance reports with FibroGen Inc.2025 Macro Impact & Verified Momentum Watchlists - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Real time social sentiment graph for FibroGen Inc.Earnings Beat & Intraday High Probability Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is now a turning point for FibroGen Inc.2025 Price Action Summary & AI Driven Price Forecasts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Real time scanner hits for FibroGen Inc. explainedTrade Risk Assessment & Daily Volume Surge Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will FibroGen Inc. (1FG0) stock see valuation expansion2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Long term hold vs stop loss in FibroGen Inc.2025 Trading Volume Trends & Entry Point Confirmation Signals - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Live market analysis of FibroGen Inc.Buy Signal & Expert Approved Momentum Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Reversal indicators forming on FibroGen Inc. stockInflation Watch & Fast Exit and Entry Strategy Plans - newser.com

Oct 06, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 05:46:29 - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

What analysts say about FibroGen Inc stockMid Cap Growth Trends & Maximize ROI With Proven Growth Stocks - earlytimes.in

Oct 02, 2025
pulisher
Oct 01, 2025

FibroGen Inc Stock Analysis and ForecastEquity Performance Review & High Return Portfolio Growth - earlytimes.in

Oct 01, 2025
pulisher
Sep 29, 2025

What drives FibroGen Inc stock priceMonthly Performance Summary & Reap the Rewards of Patience + Planning - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

What analysts say about FibroGen Inc 1FG0 stockBollinger Bands Signals & Exceptional Capital Growth - earlytimes.in

Sep 29, 2025
pulisher
Sep 25, 2025

FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress - Investing.com Nigeria

Sep 25, 2025
pulisher
Sep 25, 2025

FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress By Investing.com - Investing.com South Africa

Sep 25, 2025
pulisher
Sep 25, 2025

William Blair Remains a Hold on FibroGen (FGEN) - The Globe and Mail

Sep 25, 2025
pulisher
Sep 25, 2025

H.C. Wainwright Maintains FibroGen(FGEN.US) With Buy Rating, Maintains Target Price $43 - 富途牛牛

Sep 25, 2025
pulisher
Sep 24, 2025

FibroGen initiates phase 2 trial of FG-3246 for prostate cancer By Investing.com - Investing.com South Africa

Sep 24, 2025
pulisher
Sep 24, 2025

FibroGen initiates phase 2 trial of FG-3246 for prostate cancer - Investing.com India

Sep 24, 2025
pulisher
Sep 24, 2025

FGEN: HC Wainwright & Co. Reiterates 'Buy' Rating with $43 Targe - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

FibroGen (FGEN) Launches Phase 2 Trial for Antibody-Drug Conjuga - GuruFocus

Sep 24, 2025

Fibrogen Inc Stock (FGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Fibrogen Inc Stock (FGEN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Wettig Thane
CEO
Mar 24 '25
Buy
0.35
145,000
50,663
543,329
Schoeneck James A
Director
Mar 20 '25
Buy
0.35
250,000
88,000
323,722
Schoeneck James A
Director
Mar 21 '25
Buy
0.34
50,000
17,040
373,722
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):